M4MM
Cronos Targets Europe Through Dutch Cannabis Leader Acquisition
TORONTO – Cronos Group Inc. has agreed to buy CanAdelaar B.V., the top supplier in the Netherlands' controlled adult-use Cannabis program, for $67 million upfront plus performance incentives. The move marks Cronos's first major step ...
Craft Cannabis Market Projects Steady Climb to $12.3B by 2031
LOS ANGELES – Small-scale producers in the Cannabis industry are gaining ground as buyers turn toward premium, handcrafted options, with the craft segment expected to double in value over the next five years. A report ...
FDA Signals Shift to Single Phase 3 Trials for Drug Approvals, Opening Door for Faster Psychedelic Therapies
LOS ANGELES – The Food and Drug Administration is preparing to overhaul its evidence requirements for new drug approvals, making a single well-designed Phase 3 trial the standard rather than the exception. This adjustment, outlined ...
OPINION: Industrial hemp just got ‘future proofed.’
NEW YORK- Industrial hemp just received the clearest signal yet that it's not a fad, not a loophole, and not going away. It was effectively declared “future proof.” When Congress passed the funding bill to ...
EU Cannabis Imports Explained: Rules, Regulations, Safety & Quality Control
LOS ANGELES – Germany's medical Cannabis imports reached 56.9 tons in Q3 2025, a 19% jump from the prior period and a fresh record that highlights the market's relentless pull. With an estimated 900k prescriptions ...
Gallup Reveals First Dip in Years for Cannabis Legalization Public Support
LOS ANGELES – A fresh Gallup survey reveals that 64% of American adults now back making Cannabis use legal, a figure that marks the first decline in overall support since 2019 and pulls back from ...
New York Updates Cannabis Packaging, Labeling, and Advertising Regulations
NEW YORK – The New York State Cannabis Control Board finalized amendments to its packaging, labeling, marketing, and advertising regulations, marking a significant step in refining the state's adult-use Cannabis market. The changes aim to ...
Cronos Targets Europe Through Dutch Cannabis Leader Acquisition
TORONTO – Cronos Group Inc. has agreed to buy CanAdelaar B.V., the top supplier in the Netherlands' controlled adult-use Cannabis program, for $67 million upfront plus performance incentives. The move marks Cronos's first major step ...
Craft Cannabis Market Projects Steady Climb to $12.3B by 2031
LOS ANGELES – Small-scale producers in the Cannabis industry are gaining ground as buyers turn toward premium, handcrafted options, with the craft segment expected to double in value over the next five years. A report ...
FDA Signals Shift to Single Phase 3 Trials for Drug Approvals, Opening Door for Faster Psychedelic Therapies
LOS ANGELES – The Food and Drug Administration is preparing to overhaul its evidence requirements for new drug approvals, making a single well-designed Phase 3 trial the standard rather than the exception. This adjustment, outlined ...
Humboldt Family Farms: Terroir and Cannabis
The concept of terroir, traditionally rooted in French viticulture, refers to the unique set of environmental factors that influence the growth and characteristics of a crop. While usually associated with wine, the application of terroir ...
Texas Republicans Approve Total Ban on Hemp-Derived THC Products
DALLAS-In a sweeping move that could reshape Texas' booming hemp industry, the state House of Representatives has passed an amended version of Senate Bill 3 that bans all hemp products containing any form or amount ...
Analysis: Germany Legalized Cannabis. Now the Real Work Begins.
BERLIN-On April 1, 2024, Germany made history by legalizing adult-use cannabis. But legalization was only the first step. More than a year later, the rollout has exposed the complexities of implementing cannabis reform in a ...
Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Preclinical Fibromyalgia Study
LOS ANGELES- Silo Pharma Inc. a developmental-stage biopharmaceutical company, announced that its investigational ketamine implant, SP-26, met all primary endpoints in a preclinical study targeting fibromyalgia. The study, conducted in minipigs, assessed the implant's safety, ...
Tilray Medical Introduces Good Supply Cannabis Brand to German Market
LOS ANGELES- Tilray Medical, a division of Tilray Brands Inc has launched its Canadian cannabis brand, Good Supply, in Germany. This expansion aims to provide German medical cannabis patients with access to a range of ...
MariMed Reports Q1 2025 Financial Results
LOS ANGELES- MariMed Inc. a multi-state cannabis operator, reported its financial results for the first quarter ended March 31, 2025. Financial Overview Revenue: $38.0 million, a slight increase from $37.9 million in Q1 2024. Gross ...
Why Bob Hoban Is Defending Steve DeAngelo—And What It Reveals About Cannabis Policy
LOS ANGELES- In cannabis industry discourse, facts can be overshadowed by simplified narratives. One such claim—widely circulated in trade circles—is that Steve DeAngelo, founder of Harborside and a prominent figure in the legalization movement, was ...
DEA Grants Import Permit for Psilocybin Truffles to Red Light Holland and Irvine Labs
LOS ANGELES- Red Light Holland Corp, an Ontario-based producer of psilocybin truffles, announced that its U.S. partner, Irvine Labs, has received a Controlled Substances Import Permit from the Drug Enforcement Administration (DEA). This authorization allows ...
Glass House Brands Proposes Long-Term Incentive Plan Tied to Share Price Performance
LOS ANGELES- Glass House Brands Inc. a vertically integrated cannabis company, has announced the mailing of its management information circular to shareholders ahead of its annual and special meeting scheduled for June 20, 2025. At ...
Minnesota Legislature Advances Cannabis Market Framework to Governor
LOS ANGELES- Minnesota lawmakers have passed a comprehensive bill aimed at refining the state's adult-use cannabis program, forwarding it to Governor Tim Walz for approval. The legislation, known as SF 2370, seeks to address regulatory ...
Cannabis in Psychedelic Therapy: Potential and Precautions
LOS ANGELES- The integration of cannabis into psychedelic-assisted psychotherapy is gaining attention as a potential treatment for various mental health conditions, including post-traumatic stress disorder (PTSD), depression, and anxiety. This approach involves administering cannabis in ...
Cybin Partners with Thermo Fisher for U.S. Manufacturing
LOS ANGELES- Cybin Inc. a neuropsychiatry company, has announced a collaboration with Thermo Fisher Scientific to support the Phase 3 clinical supply and potential commercial manufacturing of CYB003, its proprietary deuterated psilocin analog, for the ...
Rubicon Organics Appoints Glen Ibbott as Interim CFO
LOS ANGELES- Rubicon Organics Inc. a Canadian producer of certified organic cannabis products, has appointed Glen Ibbott as Interim Chief Financial Officer, effective May 15, 2025. This leadership change follows the departure of Janis Risbin ...
TILT Holdings Reports First Quarter 2025 Financial Results
LOS ANGELES- TILT Holdings Inc. announced its financial results for the first quarter ended March 31, 2025, reflecting a year-over-year revenue decline and continued strategic realignment towards its Jupiter inhalation technology business. Financial Performance The ...
High-Paying Roles in the Cannabis Industry
LOS ANGELES- As the cannabis industry continues its expansion across the United States, it presents a variety of high-paying career opportunities. Positions such as cultivation directors, compliance officers, and extraction technicians are in demand, offering ...
